These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32206714)

  • 21. The sphingosine-1-phosphate/sphingosine-1-phosphate receptor 2 axis regulates early airway T-cell infiltration in murine mast cell-dependent acute allergic responses.
    Oskeritzian CA; Hait NC; Wedman P; Chumanevich A; Kolawole EM; Price MM; Falanga YT; Harikumar KB; Ryan JJ; Milstien S; Sabbadini R; Spiegel S
    J Allergy Clin Immunol; 2015 Apr; 135(4):1008-1018.e1. PubMed ID: 25512083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin released from mast cells activated by circulating MCP-1 initiates the microvascular phase of the systemic inflammation of alveolar hypoxia.
    Chao J; Blanco G; Wood JG; Gonzalez NC
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2264-70. PubMed ID: 21963836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Directional mast cell degranulation of tumor necrosis factor into blood vessels primes neutrophil extravasation.
    Dudeck J; Kotrba J; Immler R; Hoffmann A; Voss M; Alexaki VI; Morton L; Jahn SR; Katsoulis-Dimitriou K; Winzer S; Kollias G; Fischer T; Nedospasov SA; Dunay IR; Chavakis T; Müller AJ; Schraven B; Sperandio M; Dudeck A
    Immunity; 2021 Mar; 54(3):468-483.e5. PubMed ID: 33484643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nerve growth factor activates mast cells through the collaborative interaction with lysophosphatidylserine expressed on the membrane surface of activated platelets.
    Kawamoto K; Aoki J; Tanaka A; Itakura A; Hosono H; Arai H; Kiso Y; Matsuda H
    J Immunol; 2002 Jun; 168(12):6412-9. PubMed ID: 12055260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tetraspanin CD63 is required for efficient IgE-mediated mast cell degranulation and anaphylaxis.
    Kraft S; Jouvin MH; Kulkarni N; Kissing S; Morgan ES; Dvorak AM; Schröder B; Saftig P; Kinet JP
    J Immunol; 2013 Sep; 191(6):2871-8. PubMed ID: 23945142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet activating factor does not release histamine from human dispersed cutaneous mast cells.
    Thomas G; Church MK
    Clin Exp Allergy; 1990 Jul; 20(4):377-82. PubMed ID: 1695868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocannabinoids limit excessive mast cell maturation and activation in human skin.
    Sugawara K; Bíró T; Tsuruta D; Tóth BI; Kromminga A; Zákány N; Zimmer A; Funk W; Gibbs BF; Zimmer A; Paus R
    J Allergy Clin Immunol; 2012 Mar; 129(3):726-738.e8. PubMed ID: 22226549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Elucidation of Mast Cell Activation Mechanism Mediated by Purinergic Signaling].
    Yoshida K
    Yakugaku Zasshi; 2021; 141(9):1057-1061. PubMed ID: 34471006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging Roles of Mast Cells in the Regulation of Lymphatic Immuno-Physiology.
    Pal S; Nath S; Meininger CJ; Gashev AA
    Front Immunol; 2020; 11():1234. PubMed ID: 32625213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response.
    Nilsson G; Metcalfe DD; Taub DD
    Immunology; 2000 Feb; 99(2):314-9. PubMed ID: 10692052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet activating factor: A potential biomarker in acute coronary syndrome?
    Palur Ramakrishnan AV; Varghese TP; Vanapalli S; Nair NK; Mingate MD
    Cardiovasc Ther; 2017 Feb; 35(1):64-70. PubMed ID: 27790832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of platelet endothelial cell adhesion molecule-1 (CD31) leads to increased severity of local and systemic IgE-mediated anaphylaxis and modulation of mast cell activation.
    Wong MX; Roberts D; Bartley PA; Jackson DE
    J Immunol; 2002 Jun; 168(12):6455-62. PubMed ID: 12055265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mast Cells Granular Contents Are Crucial for Deep Vein Thrombosis in Mice.
    Ponomaryov T; Payne H; Fabritz L; Wagner DD; Brill A
    Circ Res; 2017 Sep; 121(8):941-950. PubMed ID: 28739590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-activating factor as an intercellular signal in neutrophil-dependent platelet activation.
    Zhou W; Javors MA; Olson MS
    J Immunol; 1992 Sep; 149(5):1763-9. PubMed ID: 1506691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of platelet agonists on the binding of platelet-activating factor to human platelets.
    Burgers JA; Akkerman JW
    J Lipid Mediat; 1992 Sep; 5(3):289-300. PubMed ID: 1334723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer.
    Damiani E; Ullrich SE
    Prog Lipid Res; 2016 Jul; 63():14-27. PubMed ID: 27073146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism.
    Gomi K; Zhu FG; Marshall JS
    J Immunol; 2000 Dec; 165(11):6545-52. PubMed ID: 11086097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vitro and In Vivo IgE-/Antigen-Mediated Mast Cell Activation.
    Choi HW; Abraham SN
    Methods Mol Biol; 2018; 1799():71-80. PubMed ID: 29956145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses.
    Smrž D; Bandara G; Zhang S; Mock BA; Beaven MA; Metcalfe DD; Gilfillan AM
    J Immunol Methods; 2013 Apr; 390(1-2):52-62. PubMed ID: 23357051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.